OBP-801 Active Not Recruiting Phase 1 Trials for Tumors, Solid Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02414516A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors